Therapy and clinical trials.
Cramb
R
R
D018797:Cell Cycle Proteins; D002986:Clinical Trials as Topic; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000209:etiology; D020648:Peptide Elongation Factor 1; D017354:Point Mutation / Q000235:genetics; D011506:Proteins / Q000627:therapeutic use*; D011516:Prothrombin / Q000187:drug effects; D014810:Vitamin E / Q000008:administration & dosage
D018797:Cell Cycle Proteins; C503234:EEF1A2 protein, human; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D020648:Peptide Elongation Factor 1; D011506:Proteins; D014810:Vitamin E; D011516:Prothrombin